2006
DOI: 10.2337/db06-0878
|View full text |Cite
|
Sign up to set email alerts
|

Blockade of Pancreatic Islet–Derived Ghrelin Enhances Insulin Secretion to Prevent High-Fat Diet–Induced Glucose Intolerance

Abstract: The gastric hormone ghrelin and its receptor, growth hormone secretagogue receptor (GHSR), are expressed in pancreas. Here, we report that ghrelin is released from pancreatic islets to regulate glucose-induced insulin release. Plasma concentrations of ghrelin, as well as insulin, were higher in pancreatic veins than in arteries. GHSR antagonist and immunoneutralization of endogenous ghrelin enhanced glucose-induced insulin release from perfused pancreas, whereas exogenous ghrelin suppressed it. GHSR antagonist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

9
271
4
7

Year Published

2007
2007
2015
2015

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 216 publications
(291 citation statements)
references
References 38 publications
9
271
4
7
Order By: Relevance
“…Ghrelin modulates insulin secretion and glucose metabolism (Reimer et al, 2003), augmenting glycemia by decreasing glucose-induced insulin release from pancreatic islets (Dezaki et al, 2006). However, we found no effect of ghrelin treatment on glycemia or serum insulin levels in diabetic rats.…”
Section: Discussioncontrasting
confidence: 77%
See 1 more Smart Citation
“…Ghrelin modulates insulin secretion and glucose metabolism (Reimer et al, 2003), augmenting glycemia by decreasing glucose-induced insulin release from pancreatic islets (Dezaki et al, 2006). However, we found no effect of ghrelin treatment on glycemia or serum insulin levels in diabetic rats.…”
Section: Discussioncontrasting
confidence: 77%
“…Ghrelin has both endocrine and non-endocrine activities including regulation of food intake and energy homeostasis (Wren et al, 2001), induction of adiposity (Tschop et al, 2000), actions on insulin secretion and glucose metabolism (Egido et al, 2002;Dezaki et al, 2006;Reimer et al, 2003) and stimulation of pituitary hormones including GH, prolactin and ACTH (Kojima et al, 1999;Arvat et al, 2001;Cheng et al, 1993;Broglio et al, 2003;Tassone et al, 2003). In addition, anti-inflammatory and anti-apoptotic actions of ghrelin have been reported in different organs and tissues Dixit et al, 2004;Granado et al, 2005;Granata et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…An insulinostatic function of endogenous ghrelin within islets has been suggested [13,15,17,[29][30][31]. It was also recently shown to exert inhibitory effects on expression and production of inflammatory cytokines [32] and to attenuate the development of acute pancreatitis in rats by reducing inflammatory infiltrates of pancreatic tissues [33].…”
Section: Discussionmentioning
confidence: 99%
“…In human and rodent pancreases of neonates and adults, a few epsilon cells remain visible in marginal areas of the islets [4,5,13]. An insulinostatic function of endogenous ghrelin within islets has been suggested [15][16][17]. In fact, pharmacological, immunological and genetic blockade of ghrelin or ghrelin action in pancreatic islets all markedly enhanced glucose-induced insulin release [15][16][17].…”
Section: Introductionmentioning
confidence: 99%
“…The onset of insulin resistance and compensatory hyperinsulinemia in obesity is probably the reason for the suppression of ghrelin levels (13). Ghrelin has been characterized in earlier studies as an enhancer of insulin secretion (14,15), while more recent studies with mice have shown that the antagonism of its effects could promote the secretion of insulin and prevent glucose intolerance induced by a high-fat diet (16,17). …”
Section: Introductionmentioning
confidence: 99%